171
|
|
|
Growth differentiation factor 9 |
POF14 |
|
172
|
|
|
GDP dissociation inhibitor 1 |
1A, GDIL, MRX41, MRX48, OPHN2, RABGD1A, RABGDIA, XAP-4, XLID41 |
|
173
|
|
|
GDP dissociation inhibitor 2 |
HEL-S-46e, RABGDIB |
|
174
|
|
|
Glial cell derived neurotrophic factor |
ATF, ATF1, ATF2, HFB1-GDNF, HSCR3 |
Amphetamine or sympathomimetic abuse, Anorexia nervosa, Anxiety disorder, Bipolar disorder, Haddad syndrome, Congenital central hypoventilation syndrome, Degenerative disorder, Diverticular disease, Dyskinesia, drug-induced, Epilepsy, Glioblastoma, Glioma, Glomerulonephritis, Hirschsprung disease, Huntington disease, Hyperalgesia, Major depressive disorder, Neurodegenerative disorder, Obesity, Oligodendroglioma, Parkinson disease, Secondary parkinson disease, Pheochromocytoma, Prostate cancer, Retinal degeneration, Schizophrenia, Status epilepticus, DepressionView all (13 more) |
175
|
|
|
Glycerophosphodiester phosphodiesterase domain containing 1 |
GDE4 |
|
176
|
|
|
Glycerophosphodiester phosphodiesterase domain containing 3 |
GDE7 |
|
177
|
|
|
Glycerophosphodiester phosphodiesterase domain containing 5 |
GDE2, PP1665 |
|
178
|
|
|
GTP binding protein overexpressed in skeletal muscle |
KIR |
|
179
|
|
|
Gem nuclear organelle associated protein 2 |
SIP1, SIP1-delta |
|
180
|
|
|
Gem nuclear organelle associated protein 4 |
HC56, HCAP1, HHRF-1, NEDMCR, p97 |
|